Abstract
e11539 Background: Health care in United states of America is undergoing paradigm shift with Congress mandating that the Medicare program tie payment to reporting on quality measures.We undertook this study to assess the compliance of breast cancer care with established quality indicators from professional societies. Methods: We undertook a retrospective study at University of Toledo Medical Center(UTMC ) after IRB approval , which included patients with stage I/II breast cancer between 2006-2010. Percentage compliance with ASCO/NCCN Quality Measures was calculated. Radiation therapy administered within 1 year of diagnosis for women younger than age 70 years receiving breast conserving surgery. Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis with AJCC T1cN0M0, or stage II or III hormone receptor–negative breast cancer. Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year of diagnosis for ER positive tumors. Results: A ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
